TILT Biotherapeutics

Helsinki, Finland · Founded 2013 · Privately Held (backing)

Developer of a biotechnology platform intended to develop oncolytic immunotherapies that will modify the tumor microenvironment and eliminate its ability to suppress immune responses to cancer. TILT Biotherapeutics is based in Helsinki, Finland and was founded in 2013. Its last reported valuation was $100 million in Jun 2024. It has raised $82 million.

Last reported valuation
$100.2M
Oct 2026
Priced at
—
Total raised
$82.0M
Last round
—

Who backs TILT Biotherapeutics?

14 investors
InvestorType
European Innovation CouncilVenture capital
European CommissionOther
Business FinlandOther
Lifeline VenturesVenture capital
TesiOther
TekesOther
Stephen IndustriesOther
European Innovation Council (Belgium)—
Horizon 2020—
Inrgrid Chen—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

TILT Biotherapeutics investors

14 investors are on record for TILT Biotherapeutics, including European Innovation Council, European Commission, Business Finland and Lifeline Ventures.

Free account
More of TILT Biotherapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch TILT Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like TILT Biotherapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View